Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.

Brussaard, H E

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. [electronic resource] - Diabetologia Jul 1997 - 843-9 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0012-186X

10.1007/s001250050758 doi


C-Peptide--blood
Cholesterol--blood
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Estradiol--therapeutic use
Estrogen Replacement Therapy
Fatty Acids, Nonesterified--blood
Female
Fibrinolysis--drug effects
Glycated Hemoglobin--analysis
Humans
Insulin Resistance
Lipids--blood
Lipoproteins--blood
Middle Aged
Plasminogen Activator Inhibitor 1--blood
Postmenopause
Tissue Plasminogen Activator--blood
Triglycerides--blood